KIR3DL2 and rheumatoid arthritis: Significantly greater expression of KIR‐3DL2 on IL‐1R+CD4+ T cells was detected in B27+ patients with AS and B27+ healthy controls compared to B27− healthy controls and RA disease controls (Figure 6B).